Immunology is defined as the study of the immune system and it is an important branch of the medical & biological sciences. Immunology deals with physiological functions of the immune system instates of both health & disease and malfunctions of the immune system in immunological disorders such as immune deficiency, allergies, hypersensitivities, transplant rejection & autoimmune disorders.
The rise in adoption of monoclonal antibody (mAb), combined with the increasing prevalence of immunological diseases is expected to boost the global immunology market growth over the forecast period. The growing research and development initiative in the monoclonal antibody segment & a large number of drugs under the segment is expected to support the global immunology market growth.
The partnership by key operating players for development of drugs to treat autoimmune disorders expected to drive the market growth. For instance, in March 2019, Eli Lilly had partnered with ImmuNext, engaged in the development of compounds on the cutting edge immunotherapy for autoimmune diseases. The goal of combining these two companies is to study and development of potential target for autoimmune disease treatments.
Furthermore, in October 2020, Abbive, Biopharmaceutical Company had collaborated with Alector, privately owned Biotechnology Company, for development and commercializes medicines to treat lzheimer's disease & other neurodegenerative disorders.
Lack of technological developments and high cost associated with treatment is major restraining factor which expected to hamper the global immunology market growth over the forecast period.
The Global Immunology Market is segmented into drug class such as Monoclonal antibody, Fusion Proteins, Immunosuppressant, Polyclonal antibody, and others, by disease indication such as Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel disease, and others. Further, market is segmented into distribution channel such as Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others.
Also, the Global Immunology Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The North America is expected to hold largest revenue share throughout the forecast period, owing to the increase in adoption of advanced immunology drugs and the increasing prevalence of autoimmune and immunological disorders. The Europe is anticipated to be the second most dominant market after North American market owing the research and development initiatives as well as the growing adoption of advanced immunology drugs, whereas, in emerging countries like India and China. Also, the increase in awareness of autoimmune and immunological disorders is propelling immunology market growth in this report.
Various key players are listed in this report such as Eli Lilly, AbbVie Inc, F.Hoffmann-La roche Ltd, Amgen Inc, Pfizer, Novartis, Astellas, Alector, ImmuNext, Merck sharp & Dohme Corp., UCB SA, etc.
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Immunology Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Immunology Market, By Drug Class
5.1 Y-o-Y Growth Comparison, By Drug Class
5.2 Global Immunology Market Share Analysis, By Drug Class
5.3 Global Immunology Market Size and Forecast, By Drug Class
5.3.1 Monoclonal antibody
5.3.2. Fusion Proteins
5.3.3. Immunosuppressant
5.3.4. Polyclonal antibody
5.3.5Others
6 Global Immunology Market, By Disease indication
6.1 Y-o-Y Growth Comparison, By Disease indication
6.2 Global Immunology Market Share Analysis, By Disease indication
6.3 Global Immunology Market Size and Forecast, By Disease indication
6.3.1 Rheumatoid Arthritis
6.3.2. Psoriatic Arthritis
6.3.3. Plaque Psoriasis
6.3.4. Ankylosing Spondylitis
6.3.5. Inflammatory Bowel disease
6.3.6.Others
7 Global Immunology Market, By Distribution Channel
7.1 Y-o-Y Growth Comparison, By Distribution Channel
7.2 Global Immunology Market Share Analysis, By Distribution Channel
7.3 Global Immunology Market Size and Forecast, By Distribution Channel
7.3. 1 Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Online Pharmacies
7.3.4. Others
8Global Immunology Market, By Region
8.1 Global Immunology Market Share Analysis, By Region
8.2 Global Immunology Market Share Analysis, By Region
8.3 Global Immunology Market Size and Forecast, By Region
9 North America Immunology Market Analysis and Forecast (2020-2030)
9.1 Introduction
9.2 North America Immunology Market Share Analysis, By Drug Class
9.3 North America Immunology Market Size and Forecast, By Disease indication
9.4 North America Immunology Market Size and Forecast, By Distribution Channel
9.5 North America Immunology Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10EuropeImmunology Market Analysis and Forecast (2020-2030)
10.1 Introduction
10.2 Europe Immunology Market Share Analysis, By Drug Class
10.3 Europe Immunology Market Size and Forecast, By Disease indication
10.4 Europe Immunology Market Size and Forecast, By Distribution Channel
10.5 Europe Immunology Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11Asia Pacific Immunology Market Analysis and Forecast (2020-2030)
11.1 Introduction
11.2 Asia Pacific Immunology Market Share Analysis, By Drug Class
11.3 Asia Pacific Immunology Market Size and Forecast, By Disease indication
11.4 Asia Pacific Immunology Market Size and Forecast, By Distribution Channel
11.5 Asia Pacific Immunology Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12Latin America Immunology Market Analysis and Forecast (2020-2030)
12.1 Introduction
12.2 Latin America Immunology Market Share Analysis, By Drug Class
12.3 Latin America Immunology Market Size and Forecast, By Disease indication
12.4 Latin America Immunology Market Size and Forecast, By Distribution Channel
12.5 Latin America Immunology Market Size and Forecast, Country
13Middle East Immunology Market Analysis and Forecast (2020-2030)
13.1 Introduction
13.2 Middle East Immunology Market Share Analysis, By Drug Class
13.3 Middle East Immunology Market Size and Forecast, By Disease indication
13.4 Middle East Immunology Market Size and Forecast, By Distribution Channel
13.5 Middle East Immunology Market Size and Forecast, By Country
14Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15Company Profiles
15.1 Eli Lilly
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. AbbVie Inc
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. F.Hoffmann-La roche Ltd
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Amgen Inc
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Pfizer
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Novartis
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Astellas
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Alector
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 ImmuNext
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Merck sharp & Dohme Corp
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
15.11 UCB SA
15.11.1 Overview
15.11.2 Offerings
15.11.3 Key Financials
15.11.4 Business Segment & Geographic Overview
15.11.5 Key Market Developments
15.11.6 Key Strategies
